Department of Neurology, Victor Babes University of Medicine and Pharmacy, Piata Eftimie Murgu 2, Timisoara 300041, Romania.
Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Oxford OX2 6GG, UK.
J Travel Med. 2021 Oct 11;28(7). doi: 10.1093/jtm/taab133.
Air travel may be associated with viruses spread via infected passengers and potentially through in-flight transmission. Given the novelty of the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, transmission associated with air travel is based on transmission dynamics of other respiratory viruses. Our objective was to provide a rapid summary and evaluation of relevant data on SARS-CoV-2 transmission aboard aircraft, report policy implications and to highlight research gaps requiring urgent attention.
We searched four electronic databases (1 February 2020-27 January 2021) and included studies on SARS-CoV-2 transmission aboard aircraft. We assessed study quality based on five criteria and reported important findings.
We included 18 studies on in-flight SARS-CoV-2 transmission (130 unique flights) and 2 studies on wastewater from aircraft. The quality of evidence from most published studies was low. Two wastewater studies reported PCR-positive samples with high cycle threshold values (33-39). Index case definition was heterogeneous across studies. The proportion of contacts traced ranged from 0.68 to 100%. Authors traced 2800/19 729 passengers, 140/180 crew members and 8/8 medical staff. Altogether, 273 index cases were reported, with 64 secondary cases. Three studies, each investigating one flight, reported no secondary cases. Secondary attack rate among studies following up >80% of passengers and crew (including data on 10 flights) varied between 0 and 8.2%. The studies reported on the possibility of SARS-CoV-2 transmission from asymptomatic, pre-symptomatic and symptomatic individuals. Two studies performed viral cultures with 10 positive results. Genomic sequencing and phylogenetic analysis were performed in individuals from four flights.
Current evidence suggests SARS-CoV-2 can be transmitted during aircraft travel, but published data do not permit any conclusive assessment of likelihood and extent. The variation in design and methodology restricts the comparison of findings across studies. Standardized guidelines for conducting and reporting future studies of transmission on aircraft should be developed.
航空旅行可能与受感染乘客传播的病毒以及潜在的机上传播有关。鉴于新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)病毒的新颖性,与航空旅行相关的传播是基于其他呼吸道病毒的传播动力学。我们的目的是提供有关 SARS-CoV-2 在飞机上传播的相关数据的快速总结和评估,报告政策影响,并强调需要紧急关注的研究空白。
我们检索了四个电子数据库(2020 年 2 月 1 日至 2021 年 1 月 27 日),并纳入了关于 SARS-CoV-2 在空中传播的研究。我们根据五个标准评估研究质量,并报告重要发现。
我们纳入了 18 项关于飞行中 SARS-CoV-2 传播的研究(130 次单独航班)和 2 项关于飞机废水的研究。大多数已发表研究的证据质量较低。两项废水研究报告了 PCR 阳性样本,循环阈值较高(33-39)。索引病例的定义在研究之间存在差异。接触者追踪的比例范围为 0.68 至 100%。作者追踪了 2800/19729 名乘客、140/180 名机组人员和 8/8 名医务人员。总共报告了 273 例索引病例,其中 64 例为二级病例。有三项研究,每项研究都调查了一架航班,报告没有二级病例。在对 80%以上的乘客和机组人员进行随访的研究中(包括 10 次航班的数据),二次攻击率在 0 至 8.2%之间有所不同。这些研究报告了无症状、症状前和有症状个体传播 SARS-CoV-2 的可能性。两项研究进行了病毒培养,结果均为阳性。对来自四架航班的个体进行了基因组测序和系统发育分析。
目前的证据表明,SARS-CoV-2 可以在飞机旅行中传播,但已发表的数据不允许对可能性和程度进行任何结论性评估。设计和方法的差异限制了对研究结果的比较。应制定在飞机上进行传播研究的标准化指南。